CVS HEALTH Corp is expected to release its Q2 2026 10-Q filing in the upcoming earnings season. Last quarter: CVS Health delivered a strong Q1 2026 with revenue rising 6.2% YoY to $100.4B and net income surging 65.4% to $2.9B, driven by improved operating leverage and margin expansion.
Drawn from management commentary in the Q1 2026 10-Q:
Total revenue grew 6.2% YoY to $100.4B in Q1 2026 (from $94.6B in Q1 2025), reflecting continued volume growth across CVS's diversified health services platform including pharmacy benefits, retail, and health care segments.
Operating income jumped 38.7% YoY to $4.68B from $3.37B, with operating margin expanding approximately 110 basis points to 4.66%, suggesting meaningful improvement in cost efficiency and business mix relative to the prior year period.
Net income increased 65.4% YoY to $2.94B, with diluted EPS rising 63.1% to $2.30 from $1.41, indicating that bottom-line profitability improved substantially beyond just top-line growth.
Revenue
$100.43B
++6.17% YoY
EPS (Basic)
$2.31
++63.83% YoY
Operating Income
$4.68B
++38.71% YoY
Add CVS to your watchlist to get the AI analysis in your inbox within minutes of the 10-Q filing.